The increased proliferation seen in PAH-PASMC is associated with a KLF-5-dependent up-regulation of cyclin B1, confirming previous findings in systemic vessels [30] and cancer [31] (Figure 3C). This evidence concerns the gene KLF5 and pulmonary arterial hypertension.